Manuka IncOTC Pink - Limited Information:MNKA
- LAST PRICE0.0500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Manuka Inc | 5.6M | -3.9x | --- |
Halberd Corp | 5.3M | 3.7x | --- |
Lipella Pharmaceuticals Inc | 4.9M | -1.0x | --- |
Ainos Inc | 6.1M | -0.3x | --- |
Silo Pharma Inc | 5.4M | -1.6x | --- |
Oragenics Inc | 5.5M | -0.1x | --- |
Company Information
Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.
Contact Information
- Headquarters
- 3 Eliezer Vardinon St.PETAH TIKVA, NY, Israel 4959507
- Phone
- 646-233-1454
- Fax
- 302-655-5049
Executives
- Chief Executive Officer, Director
- Shimon Citron
- Chief Financial Officer
- David Dana
- Chief Operating Officer
- Haim Tabak
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.6M |
|---|---|
Revenue (TTM) | $671.0K |
Shares Outstanding | 112.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.68 |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -176.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
